CA2261151A1 - Transformation of pichia methanolica - Google Patents
Transformation of pichia methanolicaInfo
- Publication number
- CA2261151A1 CA2261151A1 CA002261151A CA2261151A CA2261151A1 CA 2261151 A1 CA2261151 A1 CA 2261151A1 CA 002261151 A CA002261151 A CA 002261151A CA 2261151 A CA2261151 A CA 2261151A CA 2261151 A1 CA2261151 A1 CA 2261151A1
- Authority
- CA
- Canada
- Prior art keywords
- methanolica
- dna molecules
- cells
- transformation
- pichia methanolica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Methods for transforming Pichia methanolica, and DNA molecules useful in transformation of P. methanolica, are disclosed. P. methanolica cells are exposed, in the presence of DNA molecules, to a pulsed electric field having a field strength of from 2.5 to 4.5 kV/cm and a pulse duration of from 1 to 40 milliseconds, whereby the DNA molecules are introduced into the cells. The DNA
molecules may comprise an expression unit that includes a transcription promoter of a P. methanolica gene operably linked to a segment encoding a polypeptide or protein of interest. The DNA molecules may also encode a selectable marker, such as a P. methanolica ADE2 gene. Cells transformed according to the invention may be used in production systems for the preparation of proteins of commercial importance.
molecules may comprise an expression unit that includes a transcription promoter of a P. methanolica gene operably linked to a segment encoding a polypeptide or protein of interest. The DNA molecules may also encode a selectable marker, such as a P. methanolica ADE2 gene. Cells transformed according to the invention may be used in production systems for the preparation of proteins of commercial importance.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68350096A | 1996-07-17 | 1996-07-17 | |
US08/683,500 | 1996-07-17 | ||
PCT/US1997/012581 WO1998002565A1 (en) | 1996-07-17 | 1997-07-14 | TRANSFORMATION OF $i(PICHIA METHANOLICA) |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2261151A1 true CA2261151A1 (en) | 1998-01-22 |
CA2261151C CA2261151C (en) | 2003-09-16 |
Family
ID=24744316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002261151A Expired - Fee Related CA2261151C (en) | 1996-07-17 | 1997-07-14 | Transformation of pichia methanolica |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2002515746A (en) |
AU (1) | AU718510B2 (en) |
CA (1) | CA2261151C (en) |
IL (1) | IL128073A0 (en) |
WO (1) | WO1998002565A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL349068A1 (en) | 1998-09-23 | 2002-07-01 | Zymogenetics Inc | Cytokine receptor zalpha11 |
KR100699524B1 (en) | 1999-01-07 | 2007-03-23 | 지모제넥틱스, 인코포레이티드 | SOLUBLE RECEPTOR BR43x2 AND METHODS OF USING |
US7833529B1 (en) | 1999-01-07 | 2010-11-16 | Zymogenetics, Inc. | Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor |
HU229148B1 (en) | 1999-03-09 | 2013-09-30 | Zymogenetics Inc Seattle | Human cytokine as ligand of the zalpha receptor and uses thereof |
WO2000056903A2 (en) * | 1999-03-22 | 2000-09-28 | Zymogenetics, Inc. | IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA) |
US6258559B1 (en) | 1999-03-22 | 2001-07-10 | Zymogenetics, Inc. | Method for producing proteins in transformed Pichia |
CA2378519C (en) | 1999-07-07 | 2011-01-25 | Zymogenetics, Inc. | Human cytokine receptor |
EP1242600B1 (en) | 1999-12-23 | 2010-03-03 | ZymoGenetics, Inc. | Cytokine zcyto18 |
CA2412239C (en) | 2000-06-26 | 2013-05-28 | Zymogenetics, Inc. | Cytokine receptor zcytor17 |
AU2002238052A1 (en) | 2001-02-20 | 2002-09-04 | Zymogenetics, Inc. | Antibodies that bind both bcma and taci |
BRPI0209933B8 (en) | 2001-05-24 | 2021-05-25 | Zymogenetics Inc | fusion protein, and, nucleic acid molecule |
EP2305311A3 (en) | 2001-10-10 | 2011-07-20 | BioGeneriX AG | Glycoconjugation of peptides |
ES2516041T3 (en) | 2001-10-10 | 2014-10-30 | Ratiopharm Gmbh | Remodeling and glycoconjugation of human growth hormone (hGH) |
WO2003040313A2 (en) | 2001-11-05 | 2003-05-15 | Zymogenetics, Inc | Il-21 antagonists |
ES2382800T3 (en) | 2002-01-18 | 2012-06-13 | Zymogenetics, Inc. | Multimers Zcytor17 cytokine receptors |
ES2310660T3 (en) | 2002-01-18 | 2009-01-16 | Zymogenetics, Inc. | CYTOQUINE (BINDING ZCYTOR17). |
CN101676728A (en) | 2002-04-19 | 2010-03-24 | 津莫吉尼蒂克斯公司 | cytokine receptor |
MXPA05010773A (en) | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Glycopegylation methods and proteins/peptides produced by the methods. |
CN101001951B (en) | 2004-08-02 | 2011-06-15 | 巴斯福植物科学有限公司 | Method for isolation of transcription termination sequences |
EP1856156A2 (en) | 2005-02-08 | 2007-11-21 | ZymoGenetics, Inc. | Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
ES2772674T3 (en) | 2005-05-12 | 2020-07-08 | Zymogenetics Inc | Compositions and methods for modulating immune responses |
AU2006278229B2 (en) | 2005-08-09 | 2011-10-27 | Ares Trading S.A. | Methods for treating B-cell malignancies using TACI-Ig fusion molecule |
JP5118037B2 (en) | 2005-08-09 | 2013-01-16 | ザイモジェネティクス, インコーポレイテッド | Methods for the treatment and prevention of abnormal cell proliferation using TACI fusion molecules |
EP1931697B1 (en) | 2005-09-28 | 2010-09-15 | ZymoGenetics, Inc. | Il-17a and il-17f antagonists and methods of using the same |
AU2007249223B2 (en) | 2006-05-15 | 2012-08-02 | Ares Trading S.A. | Methods for treating autoimmune diseases using a TACI-Ig fusion molecule |
KR101700711B1 (en) | 2007-11-21 | 2017-01-31 | 로스킬드 유니베르시테트 | Polypeptides comprising an ice-binding activity |
CA2705925C (en) * | 2007-12-19 | 2019-03-12 | Glycofi, Inc. | Yeast strains for protein production |
US8653020B2 (en) | 2008-01-25 | 2014-02-18 | Aarhus Universitet | Selective exosite inhibition of PAPP-A activity against IGFBP-4 |
JP5985826B2 (en) | 2008-12-16 | 2016-09-06 | ノバルティス アーゲー | Yeast display system |
JP2015509005A (en) | 2012-02-01 | 2015-03-26 | シンセティック ジェノミクス インコーポレーテッド | Materials and methods for the synthesis of nucleic acid molecules that minimize errors |
WO2014202089A2 (en) | 2013-06-18 | 2014-12-24 | Roskilde Universitet | Variants of anti-freeze polypeptides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4857467A (en) * | 1986-07-23 | 1989-08-15 | Phillips Petroleum Company | Carbon and energy source markers for transformation of strains of the genes Pichia |
JP2000500014A (en) * | 1995-11-09 | 2000-01-11 | ザイモジェネティクス,インコーポレイティド | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
-
1997
- 1997-07-14 IL IL12807397A patent/IL128073A0/en unknown
- 1997-07-14 WO PCT/US1997/012581 patent/WO1998002565A1/en not_active Application Discontinuation
- 1997-07-14 JP JP50632298A patent/JP2002515746A/en not_active Ceased
- 1997-07-14 AU AU38039/97A patent/AU718510B2/en not_active Ceased
- 1997-07-14 CA CA002261151A patent/CA2261151C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3803997A (en) | 1998-02-09 |
CA2261151C (en) | 2003-09-16 |
WO1998002565A1 (en) | 1998-01-22 |
JP2002515746A (en) | 2002-05-28 |
IL128073A0 (en) | 1999-11-30 |
AU718510B2 (en) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2261151A1 (en) | Transformation of pichia methanolica | |
EP1672070A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
EP1683864A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO1999014328A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO1999028462A3 (en) | Polypeptides and nucleic acids encoding the same | |
AU3774300A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000015796A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000032776A3 (en) | Secreted amd transmembrane polypeptides and nucleic acids encoding the same | |
AU8127494A (en) | Chimeric proteins comprising borrelia polypeptides: uses therefor | |
EP0760849A4 (en) | Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof | |
EP1688430A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000043419A3 (en) | Exocytosis pathway proteins and methods of use | |
CA2329144A1 (en) | New peptide fragments for protein purification | |
EP1241179A3 (en) | Human cornichon-like protein and nucleic acids encoding it | |
EP2050762A3 (en) | Human cornichon-like protein and nucleic acids encoding it | |
EP1251139A3 (en) | Human mindin-like protein and nucleic acids encoding it | |
EP1659177A3 (en) | Secreted and transmembrane polypeptides and nucleic acids ancoding the same | |
EP1241186A3 (en) | Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same | |
WO1999042586A3 (en) | Exo1 and exo2, exocytotic proteins | |
EP1659131A3 (en) | Polypeptides and nucleic acids encoding the same | |
EP1612220A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
EP1247817A3 (en) | Human CD23-like protein and nucleic acids encoding it | |
EP1241252A3 (en) | Human enteropeptidase-like protein and nucleic acids encoding it | |
EP1241180A3 (en) | Human A33 antigen-like protein and nucleic acids encoding it | |
EP1241251A3 (en) | Human prostasin-like protein and nucleic acids encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |